With Ozempic and Mounjaro leading the charge, clinicians now have potent tools to address both glycemic control and weight management in one comprehensive approach
Its that over 40% of privately insured adults qualify for these drugs based on medical guidelines, but only 3% currently take them
As maintenance dosing gains acceptance as a GLP-1 treatment strategy, companies promoting digital health subscription programs built around behavior change will need to prove those services deliver greater long-term value than staying on medication
When to contact your provider: Persistent vomiting (more than 12 hours) Severe abdominal pain Signs of pancreatitis (pain radiating to the back, fever, rapid pulse) No weight loss after 8 weeks at the same dose Hypoglycemic symptoms (shakiness, confusion, sweating) if you're on other diabetes medications The 16-week decision point: At 16 weeks (four months), you and your provider should evaluate total weight loss
Synergistic Effects on Overall Health Together, B12 and iron have a powerful effect on health